Journal Article

Restored TDCA and valine levels imitate the effects of bariatric surgery

Azuma, Haruhito, Cetina Biefer, Hector Rodriguez, Sheu, Eric, Krenzien, Felix, Tullius, Stefan G, Pratschke, Johann, Maenosono, Ryoichi, Elkhal, Abdallah, Abdi, Reza, Zhou, Hao, Uehara, Hirofumi, Alegre, Maria-Luisa, Heinbokel, Timm, Nian, Yeqi, Desai, Bhavna N, Quante, Markus, Tavakkoli, Ali, Perkins, David, Lo, Tammy, Iske, Jasper, Falk, Christine S, Banks, Alexander S, Matsunaga, Tomohisa

2021

Overview

Obesity is widespread and linked to various co-morbidities. Bariatric surgery has been identified as the only effective treatment, promoting sustained weight loss and the remission of co-morbidities. Metabolic profiling was performed on diet-induced obese (DIO) mice, lean mice, and DIO mice that underwent sleeve gastrectomies (SGx). In addition, mice were subjected to intraperitoneal (i.p.) injections with taurodeoxycholic acid (TDCA) and valine. Indirect calorimetry was performed to assess food intake and energy expenditure. Expression of appetite-regulating hormones was assessed through quantification of isolated RNA from dissected hypothalamus tissue. Subsequently, i.p. injections with a melanin-concentrating hormone (MCH) antagonist and intrathecal administration of MCH were performed and weight loss was monitored. Mass spectrometric metabolomic profiling revealed significantly reduced systemic levels of TDCA and L-valine in DIO mice. TDCA and L-valine levels were restored after SGx in both human and mice to levels comparable with lean controls. Systemic treatment with TDCA and valine induced a profound weight loss analogous to effects observed after SGx. Utilizing indirect calorimetry, we confirmed reduced food intake as causal for TDCA/valine-mediated weight loss via a central inhibition of the MCH. In summary, we identified restored TDCA/valine levels as an underlying mechanism of SGx-derived effects on weight loss. Of translational relevance, TDCA and L-valine are presented as novel agents promoting weight loss while reversing obesity-associated metabolic disorders. This work has been supported in part by a grant from NIH (UO-1 A1 132898 to S.G.T., DP and MA). M.Q. was supported by the IFB Integrated Research and Treatment Centre Adiposity Diseases (Leipzig, Germany) and the German Research Foundation (QU 420/1-1). J.I. was supported by the Biomedical Education Program (BMEP) of the German Academic Exchange Service (DAAD). T.H. (HE 7457/1-1) and F.K. (KR 4362/1-1) were supported by the German Research Foundation (DFG). H.R.C.B. was supported the Swiss Society of Cardiac Surgery. Y.N. was supported by the Chinese Scholarship Council (201606370196) and Central South University. H.U., T.M. and R.M. were supported by the Osaka Medical Foundation. C.S.F. was supported by the German Research Foundation (DFG, SFB738, B3).

• Publisher: eLife Science Publications, Ltd,eLife Sciences Publications Ltd,eLife Sciences Publications, Ltd
• Subject: Acids / Adipose tissue / Amino acids / Analysis / Animals / Appetite / bariatric surgery / Bariatric Surgery - adverse effects / BCAA / Bile / Body weight loss / Calorimetry / Chemical compounds / Data analysis / Diabetes / Diet / Energy expenditure / Food intake / Gastrectomy - adverse effects / Gastrointestinal surgery / Glucose / Heart surgery / Hypothalamus / Injections, Intraperitoneal / Mass spectrometry / Medical research / Medicine / Medicine, Experimental / Melanin / Melanin-concentrating hormone / melanocortin / Metabolic disorders / Metabolism / Metabolites / Metabolome / Metabolomics / Mice / Mice, Inbred C57BL / Mice, Obese / Obesity / Peptides / Remission / RNA / Software / Surgery / Taurodeoxycholic acid / Taurodeoxycholic Acid - administration & dosage / Taurodeoxycholic Acid - metabolism / Type 2 diabetes / Valine / Valine - administration & dosage / Valine - metabolism / Weight control / weight loss / Weight loss maintenance